CLINICAL_TRIALS
research
· 2024-07-09
Clinical Trial Update: A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma [Phase 1]
Summary
Phase 1 trial of JMKX003948 tablets in metastatic renal cell carcinoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jemincare | Conditions: Renal Cell Carcinoma Metastatic | Phase 1 | Status: RECRUITING